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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
We will assess the overall efficacy of auditory stimulation for physiological and neurodevelopmental outcomes in preterm infants (< 37
weeks' gestation), compared to standard care. In addition, we will determine specific effects of various musical and vocal interventions
for physiological, anthropometrical, social-emotional, neurodevelopmental short- and long-term outcomes in preterm infants, parental
well-being, and bonding.
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B A C K G R O U N D
Approximately 15 million infants are born preterm each year, con-
stituting more than 10% of all infants born worldwide (March 2012).
Advances in technology and treatments have increased survival
rates and reduced morbidity in preterm infants. However, preterm
birth interferes with normal brain maturation, and subsequent clin-
ical events and interventions may have additional deleterious ef-
fects (Stoll 2015; Webb 2015). Therefore, various non-pharmaco-
logical, therapeutic or individual developmental care interventions
have emerged, that aim to improve health outcomes and quality
of life for both preterm infants and their parents (Symington 2006).
Music as therapy is one such intervention, and is used increasing-
ly in neonatal intensive care units (NICU). This has been studied
in both observational and experimental designs (van der Heijden
2016).
The sense of fetal hearing has been shown to develop as early as 16
weeks' gestation (Hepper 1994). Auditory perception has already
developed when preterm infants are born. Studies suggest that the
fetus responds to sound at least as early as 25 weeks to 27 weeks
of gestational age (Clark-Gambelunghe 2015; Hepper 1994; Mon-
son 2018). Intrauterine sounds encompass characteristics of or-
ganized sound that are highly musical in nature. Maternal heart-
beat, for instance, is rhythmic, and the fetus primarily hears the
musical parameters of speech: melody, rhythm, prosody (patterns
of stress and intonation), phonemes (sounds that distinguish one
word from another) and pitch contour of the maternal voice and ex-
ternal voices (Moon 2013; Partanen 2013; Philbin 2017). Music pro-
motes neuronal activation, and many researchers suggest that mu-
sical learning starts prior to birth (Huotilainen 2010; Perani 2010). In
preterm birth, the enclosed intrauterine environment optimal for
fetal growth and maturation is abandoned too early. Aside from
other stressful experiences, such as separation from the mother,
preterm infants must also adjust to the unusual - and potentially
noxious - sound environment of an intensive care unit (Kuhn 2013;
Park 2014; Rossetti 2013).
Appropriate auditory stimulation and social contact for preterm in-
fants is desirable (Anderson 2018). Music as therapy may provide
environmental and emotional enrichment through meaningful au-
ditory stimulation and social contact (Anderson 2018; Haslbeck
2018; Loewy 2015; Shoemark 2015). This may be particularly war-
ranted following preterm birth, as preterm infants are at risk of neu-
rodevelopmental impairment, parents are at risk of post-traumatic
stress disorders and both parents and preterm babies risk bonding
difficulties (Borghini 2006; Forcada-Guex 2006; Korja 2011). How-
ever, the precise effects of various musical and vocal stimulation
types on short- and long-term outcomes in preterm infants and
their parents remain ambiguous.
Description of the condition
Preterm birth is a significant determinant of neurodevelopmen-
tal delay, and resulting impairment can have adverse long-term
health effects (Pierrat 2017). It is sometimes associated with neg-
ative quality of life consequences, and an increased financial bur-
den for the family and healthcare system (EFCNI 2011). Preterm
infants face a range of morbidities, such as bradycardia, apnoea,
anaemia, and respiratory distress syndrome. These infants are at
risk of brain injury, and may have reduced white- and grey-matter
volumes (Inder 2005). Such brain-structure abnormalities are as-
sociated with long-term neurodevelopmental impairments, includ-
ing motor dysfunction, cerebral palsy, cognitive and behavioural
problems, and deficits in executive function (Woodward 2006). Fac-
tors such as environmental noise and sensory deprivation (e.g. the
lack of the regular intrauterine rhythms of the maternal heartbeat
and the maternal voice) may also impact neurodevelopment nega-
tively (Lahav 2014; McMahon 2012; Neville 2002). For many parents,
preterm birth is a traumatic and lasting experience. They struggle
with numerous problems and concerns, such as the uncertainty of
the infant’s future, feelings of fear, guilt, loss, grief, and confusion
(Flacking 2007; Jotzo 2005; Roque 2017). These reactions may in-
crease parental stress, adversely affect the stress-coping behaviour
of their infant, and impair formation of a secure attachment (Borgh-
ini 2006; Forcada-Guex 2006; Korja 2011).
Description of the intervention
Various musical and vocal interventions have been evaluated for
efficacy in preterm infants (Haslbeck 2012; van der Heijden 2016).
They can be directed towards the infant (with or without parental
involvement), to an entire family, or even applied within the whole
NICU. The interventions aim to relax, stabilize and stimulate the in-
fant and their parents (Hanson-Abromeit 2008).
Auditory stimulation for preterm infants and their parents incor-
porates calm music sung softly or played on an instrument. Exam-
ples include: lullabies; improvised music; popular, New Age, clas-
sical or family indigenous music; songs or sounds entrained to in-
fant vital signs (i.e. synchronized with breathing or heart rate pat-
tern) or based on the acoustic intrauterine environment (womb
sounds, heartbeats and parents' voices) (Hanson-Abromeit 2008;
Haslbeck 2012; Loewy 2013; Mondanaro 2016). Music therapists,
parents, nurses, doctors, nurses and other healthcare profession-
als deliver the specific stimulation to the infants (and sometimes to
their parents). These interventions are provided in addition to stan-
dard care in the NICU, and are either performed live or recorded.
How the intervention might work
The quality of early auditory experiences may have a direct influ-
ence on the plasticity of the brain’s auditory regions, and may affect
cortex development in infants (Yan 2003). Both auditory overstim-
ulation and sensory deprivation in the NICU may adversely affect
preterm infants' short- and long-term neurobehavioural develop-
ment, as the infants are already susceptible to neurodevelopmen-
tal impairment (Pineda 2014; Wachman 2011). Studies at the inter-
face of music science and neuroscience suggest that music might
promote neurobiological processes in humans, including the mod-
ulation of synaptic plasticity (linked to learning and memory), and
might facilitate the differentiation, activation, readjustment and
growth of neurons (Abbott 2002; Rickard 2005; Sacks 2007). For in-
stance, music can alter brain activity in core structures involved in
processing emotions (Koelsch 2014). Auditory stimulation, there-
fore, is recommended to enhance psychological and physiological
health in preterm infants (Jobe 2014; Shoemark 2015).
Several systematic reviews suggest that musical and vocal inter-
ventions may have beneficial effects on preterm infants' behavioral
states, physiological parameters, sleep quality, oral feeding, and
pain (Anderson 2018; Hartling 2009; Haslbeck 2012; Hodges 2010;
Standley 2012; Tramo 2011; van der Heijden 2016). For example, a
systematic review of 1128 participants in 20 randomised control tri-
als (with at least 10 participants per group) looked at live or record-
ed music interventions, but excluded studies that used speech, nat-
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ural sounds or womb sounds (van der Heijden 2016). Due to in-
completeness and heterogeneity of data, the authors did not con-
duct any meta-analyses. The van der Heijden 2016 review suggest-
ed that music may improve heart rate, sleep, feeding and sucking
outcomes in preterm infants. A meta-analysis by Bieleninik 2016
could not confirm or refute beneficial effects on those outcomes,
but did find a favourable impact of music on the infants' respiratory
rate, and additionally demonstrated a reduction of maternal anxi-
ety. These meta-analyses included only randomised control trials
with music therapist involvement (carried out by or in consultation
with a certified or trained music therapist) (Bieleninik 2016).
Why it is important to do this review
A number of systematic reviews have demonstrated ambiguous re-
sults for the efficacy of various types of auditory stimulation on
preterm infants. Most of the reviews focused on a specific topic (e.g.
maternal voice (Krueger 2010); music (Hartling 2009); or music in-
terventions carried out by or in consultation with a trained music
therapist (Bieleninik 2016)). The authors of these reviews conclud-
ed that the heterogeneity and clinical diversity of the included stud-
ies prevented the drawing of definite conclusions about the impact
of auditory stimulation on preterm infants (Hartling 2009; Haslbeck
2012; Hodges 2010; Krueger 2010; Standley 2012; van der Heijden
2016). Therefore, a more comprehensive and rigorous systematic
review is needed to address existing controversies arising from ap-
parently conflicting studies and reviews. Firstly, we will evaluate
the overall efficacy of auditory stimulation. Then, by analysing the
impact of various types of auditory stimulation systematically with
subgroup analysis, and by focusing on the methodological quali-
ty of the included studies, we may be able to provide better guid-
ance. We may be able to determine how to use these interventions
most effectively to promote specific outcomes in preterm infants
and their parents (e.g. live versus recorded versions; sung versus in-
strumental; choices made in rendering decisions regarding length
and time of intervention, associated keys, etc.). The current review
should assist health professionals in neonatal care to make practi-
cal, evidence-based decisions about the use of musical and vocal
interventions for preterm infants and their parents. If such a low-
cost, low-risk intervention is demonstrated to be effective in sup-
porting preterm infants' neurodevelopment and parental well-be-
ing, the findings could have significant clinical implications for this
vulnerable patient population.
O B J E C T I V E S
We will assess the overall efficacy of auditory stimulation for phys-
iological and neurodevelopmental outcomes in preterm infants
(< 37 weeks' gestation), compared to standard care. In addition,
we will determine specific effects of various musical and vocal in-
terventions for physiological, anthropometrical, social-emotional,
neurodevelopmental short- and long-term outcomes in preterm in-
fants, parental well-being, and bonding.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include parallel, cluster and factorial randomised con-
trolled trials in the review. We will include the first phase of any
cross-over trials for short-term outcomes only, to avoid bias by car-
ry-over effects.
Types of participants
We will include preterm infants of less than 37 weeks' gestational
age, during hospitalisation. We will include parents only when they
are involved in the musical or vocal intervention (listening to it with
their infant, or providing it for their infant or themselves, in relation
to their infant, e.g. to support singing to their infant).
Types of interventions
We define the intervention to include any musical or vocal stimula-
tion. The intervention can be provided live or be a recording. It can
address either the infant alone or also the parents. The music inter-
vention can be combined with another intervention, such as skin-
to-skin care, but only if both arms of the study receive the additional
intervention. We will include studies that examined a combination
of interventions versus only music or voice. Also studies that com-
pare one type of music or voice to another type of music or voice
will be included and analysed separately. Music interventions dur-
ing painful procedures will be included, and analysed separately.
A parent, music therapist, musician, doctor, nurse, or other health
professional or caregiver can deliver the intervention. The interven-
tion should include either musical elements, such as rhythm and
melody, or sounds based on the acoustic intrauterine environment,
e.g. womb sounds, heartbeats, and the human voice.
The intervention should last at least five minutes and occur at least
three times to be included in the review. The intervention period
may include any time from birth to hospital discharge. We will com-
pare the interventions with standard care without musical or vo-
cal stimulation. We will exclude auditory stimulation with white
noise (noise with constant amplitude throughout audible frequen-
cy range) or digital signals. These stimulation types lack musical
parameters such as melody and prosody.
Types of outcome measures
Primary outcomes
Primary short-term outcome in preterm infants:
• change in mean oxygen saturation before and after the interven-
tion.a
Primary long-term outcome in preterm infants:
• Bayley Scales of Infant and Toddler Development (BSID-II and
III),b focusing on mean mental development index (MDI) scores
and psychomotor development index (PSI) scores at two years
of corrected age (Johnson 2008).
Primary outcome for parents:
• change in state anxiety,b defined as mean State-Trait Anxiety In-
ventory Score with 20 items and four-point Likert Scale (Spiel-
berger 1983).
Secondary outcomes
Short-term outcomes in preterm infants:
• heart rate: beats per minutea (measured by pulse oximetry or
electrocardiogram);
• respiratory rate: inspirations per minutea (measured by, e.g.
electric strain-gauges, thoracic impedance plethysmography,
nasal air-flow sensor and spirometers);
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• heart rate variabilitya (measured by low-frequency power (ms2/
Hz); high-frequency power (ms2/Hz); low frequency/ high fre-
quency ratio, reflecting the balance between sympathetic and
parasympathetic tone);
• behavioural outcomesb (measured with behavioural numerical
scores or scales for neonates, e.g. Assessment of Preterm Infant
Behavior (Als 2005));
• hospitalisation (days);
• adverse effects, including severe apnoea during the interven-
tion requiring stimulation by the neonatal care team; and
• weight gain (kg/day).
Long-term outcomes in preterm infants at five years of age:
• neurodevelopment (assessed by standardized follow-up exam-
inations, e.g. intelligence quotient (Wechsler Preschool and Pri-
mary Scale of Intelligence-Revised (WPPSI-R) (Park & Demakis
2017); Kaufmann Assessment Battery for Children (K-ABC II)
(Melchers 2009).
Secondary outcomes for parents:
• parental well-being (measured with, e.g. the Edinburgh Postna-
tal Depression Scale);
• attachmentb (measured with standardized scales, e.g. Postpar-
tum Bonding Questionnaire (Hoffenkamp 2015)).
aAssessed up to 30 minutes before, during and 30 minutes after
each musical intervention or control condition; reported at study
level as mean changes or assessed after the last measurement
round of musical intervention or control condition.
bAssessed before and after the whole intervention or control peri-
od.
Search methods for identification of studies
We will use the criteria and standard methods of Cochrane and
Cochrane Neonatal (see the Cochrane Neonatal search strategy for
specialized register). We will search for errata or retractions from in-
cluded studies published in full-text on PubMed (www.ncbi.nlm.ni-
h.gov/pubmed), and report the date this was done within the re-
view.
Electronic searches
We will conduct a comprehensive search including: Cochrane Cen-
tral Register of Controlled Trials (CENTRAL 2019, current issue) in
the Cochrane Library; Ovid MEDLINE(R) and Epub Ahead of Print, In-
Process & Other Non-Indexed Citations, Daily and Versions(R) (1946
to current); PsycINFO (1806 to present); Web of Science (1976 to
present); and CINAHL (1981 to current). We will use the following
key words: (auditory stimulation, music, voice, song, sound, vocal,
singing, womb sounds, heartbeat) along with the standard search
of Cochrane Neonatal to translate the search into all databases (Ap-
pendix 1). We will not apply language restrictions.
We will search clinical trial registries for ongoing or recently com-
pleted trials. We will search The World Health Organization’s Inter-
national Clinical Trials Registry Platform (ICTRP) (www.who.int/ic-
trp/search/en/) and the U.S. National Library of Medicine’s Clinical-
Trials.gov (clinicaltrials.gov) via Cochrane CENTRAL. Additionally,
we will search the ISRCTN Registry for any unique trials not found
through the Cochrane CENTRAL search.
Searching other resources
We will seek the reference lists of all included articles and reviews
for relevant articles not identified in the primary search. We will
seek abstracts from the proceedings of relevant academic meet-
ings, including the Paediatric Academic Societies, the European So-
ciety for Paediatric Research, the European Association of Music
Therapy, The American Music Therapy Association and the World
Federation of Music Therapy.
Data collection and analysis
We will perform data collection and analysis according to the rec-
ommendations of the Cochrane Neonatal Review Group.
Selection of studies
Two review authors (FH and TK) will independently assess study el-
igibility for inclusion in the review according to the prespecified se-
lection criteria. They will screen titles and abstracts to remove obvi-
ously irrelevant reports. The review authors will link together multi-
ple reports of the same study. They will examine full-text reports to
establish the compliance of studies with the eligibility criteria. If tri-
al eligibility is unclear, they will resolve discrepancies through dis-
cussion with the other review authors to reach a consensus. We will
list all excluded studies with reasons for exclusion. We will record
the selection process in sufficient detail to complete a PRISMA flow
diagram and 'Characteristics of excluded studies' table.
Data extraction and management
Two review authors (FH and TK) will independently conduct da-
ta extraction using and adapting the most recent version of the
Cochrane data collection form (Higgins 2011). They will pretest the
adapted version with a subset of five studies before general appli-
cation. They will use the adapted form to decide trial inclusion or
exclusion, and to extract data from eligible trials. When data ap-
pear to be missing, they will request additional information from
authors of the original reports. They will enter and cross-check data
using Review Manager 5 software (Review Manager 2014). If there
are disagreements when comparing extracted data, they will re-
solve them in consultation with the other review authors.
Assessment of risk of bias in included studies
Two review authors (FH and TK) will independently assess the
risk of bias (low, high, or unclear) of all included trials using the
Cochrane ‘Risk of bias’ tool (Appendix 2) (Higgins 2011). In cross-
over trials they will assess whether the short-term cross-over de-
sign is suitable, whether there is a carry-over effect, whether only
first period data are available, whether the analysis is correct and
whether the results are comparable with those from parallel-group
trials. The two authors will resolve discrepancies through discus-
sion with the other review authors to reach a consensus.
Measures of treatment effect
We will analyse the treatment effects of the individual trials using
Review Manager 5 (Review Manager 2014). For dichotomous data,
we will use risk ratio (RR) and risk difference (RD) with 95% confi-
dence intervals (CIs). If the difference between groups is statistical-
ly significant, we will calculate the number needed to treat for an
additional beneficial outcome (NNTB) and number needed to treat
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for an additional harmful outcome (NNTH), with their respective
CIs. We will evaluate continuous data by assessing the mean differ-
ence (MD) with its 95% CI. If studies report the same outcome but
measure it in different ways, we will use the standardized mean dif-
ference (SMD) with its 95% CI. Where summary statistics are miss-
ing, we will derive them from the accompanying P values.
We will analyse short-term cross-over trials if there is no significant
risk of a carry-over effect. We will calculate an effect estimate us-
ing the generic inverse variance method described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
We will incorporate cross-over trials into meta-analyses using the
methods described in the Cochrane Handbook for Systematic Re-
views of Interventions (Higgins 2011). If we identify cluster trials, we
will incorporate them using generic variance methods for analysis
(Higgins 2011).
Unit of analysis issues
If the following issues occur, we plan to address them according to
the methods described below.
Cluster-randomised trials
In cluster-randomised trials, groups of participants rather than in-
dividuals are randomised to different interventions. Because of
this, participant data can no longer be assumed to be independent
of one another. Unfortunately, some cluster-randomised trials are
not analysed correctly, i.e. do not take into account that the unit
of allocation (the group) is different from the unit of analysis (the
individual). If this clustering is ignored there is a unit of analysis er-
ror, which means that the resulting P values and 95% CIs will be
artificially small and lead to an inappropriately increased weight
in the meta-analysis. If cluster-randomised trials fail to report re-
sults based on appropriate analyses such as the multi-level model
or variance component analysis, we will use the methods described
in the Cochrane Handbook for Systematic Reviews of Interventions
(chapter 16.3.3) (Higgins 2011) to re-analyse these trials with appro-
priate consideration of the intracluster (or intraclass) correlation
coefficient (ICC) to estimate the effective sample size. Sensitivity
analyses will be performed to explore whether there are any differ-
ences in effects between cluster- and individually randomised trial.
Cross-over trials
Cross-over trials are suitable for evaluating interventions with a
temporary effect in the treatment of stable conditions. The princi-
pal problem is that of carry-over (a type of period-by-intervention
interaction). Since we believe that some carry-over from period one
to period two cannot be precluded in these trials in our setting, we
plan to include only the data from the first period (as suggested in
chapter 16.4.3 of the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011).
Studies with more than two intervention groups (multi-arm
studies)
If more than one comparison arm from the same trial is eligible for
inclusion in the same meta-analysis, we will either combine groups
to create a single pair-wise comparison or appropriately reduce the
sample size (e.g. of the control group) so that the same participants
do not contribute data to the meta-analysis more than once (i.e.
splitting the 'shared' group into two or more groups) according to
the methods described in the Cochrane Handbook for Systematic
Reviews of Interventions (chapter 16.5.4) (Higgins 2011). To reflect
the fact that comparisons within multi-arm studies are correlat-
ed, we will adjust the standard error of each two-arm comparison
from a multi-arm study. We will use the method proposed by Rück-
er and Schwarzer which uses back-calculated standard errors in the
weighted least-square estimator to reflect the within-study corre-
lation (Rücker 2012; Rücker 2014; Rücker 2016).
Multiple measurement of outcomes
When primary outcomes are assessed at more than one time point
in our time ranges, we will use the data from the latest time point
available in our analyses. We do not plan to adjust for multiplicity
in our review based on multiple outcome measurements.
Dealing with missing data
We will contact the authors whenever we detect that data and sta-
tistics are missing or incomplete to request further information.
However, when data are missing due to dropouts, we will include
the reported infants and examine the effect of losses in a sensitivi-
ty analysis according to risk of bias. We will contact the primary in-
vestigators. If authors are unable or unwilling to provide the data,
we will still include the study in the review and explicitly state that
data are missing.
Assessment of heterogeneity
We will perform heterogeneity tests, including the I2 statistic. When
the I2 statistic is higher than 50%, we will assess the source of
the heterogeneity by sensitivity and subgroup analysis (Subgroup
analysis and investigation of heterogeneity). We will look for evi-
dence of bias or methodological differences between trials.
Assessment of reporting biases
For outcomes reported by more than ten studies, we will prepare a
funnel plot to assess possible reporting bias.
Data synthesis
We will use the standard methods of Cochrane and the Cochrane
Neonatal Review Group to perform statistical analysis (neona-
tal.cochrane.org/resources-review-authors). We will analyse the
treatment effects of all infants in the eligible trials. We will use a
fixed-effects model to combine the data, since we expect high het-
erogeneity for most outcomes. We will calculate average estimates
of RR and RD with 95% CIs for any meta-analyses. We will use the
MD with 95% CIs for continuous outcomes that are measured in the
same way between trials. We will calculate the standardized mean
difference (SMD) with 95% CIs to combine trials that measured the
same outcome but used different scales. We will interpret individ-
ual trials separately when a meta-analysis appears to be inappro-
priate based on clinical judgement and the I2 heterogeneity test (i.e.
when I2 > 80%).
Certainty of the evidence
We will use the GRADEpro GDT Guideline Development Tool to cre-
ate a ‘Summary of findings’ table to report the quality of the ev-
idence (GRADEproGDT). We will include the following seven out-
comes in the table:
• oxygen saturation;
• respiration rate;
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• heart rate variability;
• Bayley Scales of Infant and Toddler Development at two years;
• neurodevelopment;
• parental anxiety; and
• parental well-being.
Subgroup analysis and investigation of heterogeneity
According to the heterogeneity of auditory stimulation types, we
will compare the following modalities separately, if we have a suf-




• music without voice;
• womb sounds;
• rhythmic sounds; or
• breathing sounds.
• Auditory stimulation:
• live, infant-directed or entrained music; or
• recorded or standardized music.
• Musical decision or selection:
* by parent; or
* random, unidentified or unknown.
• Duration of intervention:
* between five and 10 minutes; or
* more than 10 minutes.
• Frequency of intervention:
* between three and 7 times; or
* at least 8 times.
• Auditory stimulation:
* alone; or
* combined with other interventions (e.g. skin-to-skin care).
• Painful procedure:
* with auditory stimulation; or
* without auditory stimulation.
• Gestational age:
• extremely preterm (less than 28 weeks' gestation);
• very preterm (28 to 32 weeks' gestation);
• moderate to late preterm (32 to 37 weeks' gestation).
Given that studies in a variety of settings may not have reliable ges-
tational age and may therefore use birth weight categories, we will
include infants categorized as:
• Low birth weight (LBW) infants – defined as infants with birth
weight < 2500 g
• Very low birth weight (VLBW) infants – defined as infants with
birth weight < 1500 g
• Extremely low birth weight (ELBW) infants – defined as infants
with birth weight < 1000 g
Infants with birth weights 1500 to 2499 g will be grouped with the
moderate preterm infants, infants 1000 to 1499 g will be grouped
with the very preterm infants, and infants < 1000 g will be grouped
with the extremely preterm infants.
We will assess differences between subgroups by using the formal
test for subgroup differences in Review Manager 5.1 (Review Man-
ager 2014).
We will estimate treatment effects in individual trials and examine
heterogeneity between trials by inspecting forest plots and quan-
tifying the impact of heterogeneity by using the I2 statistic, a mea-
sure that describes the proportion of variation in point estimates
that is due to variability across studies rather than sampling error
(Deeks 2017). We will interpret results as follows:
• Less than 25%: no heterogeneity;
• 25% to 49%: low heterogeneity;
• 50% to 74%: moderate heterogeneity;
• 75% to 100%: high heterogeneity.
If we detect statistical heterogeneity, we plan to explore possible
causes (e.g. differences in study quality, participants, intervention
regimens or outcome assessments) by performing post hoc sub-
group analyses.
Sensitivity analysis
We will perform sensitivity analyses where sufficient data are avail-
able to explore methodological heterogeneity. It is worthwhile to
note that double-blinding will scarcely be possible in intervention
designs with live music. Consequently, it is all the more crucial that
the outcome assessors are blind to the data. In our sensitivity analy-
ses, we will exclude trials with high risk of bias for any of the follow-
ing: allocation concealment, adequate randomisation, blinding of
outcome assessment (Schulz 1994; Schulz 2000).
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A P P E N D I C E S
Appendix 1. Cochrane Neonatal standard search strategy
The RCT filters have been created using Cochrane's highly sensitive search strategies for identifying randomised trials (Higgins 2011). The
neonatal filters were created and tested by the Cochrane Neonatal Information Specialist.
CENTRAL via CRS Web:
1. MESH DESCRIPTOR Infant, Newborn EXPLODE ALL AND CENTRAL:TARGET
2. infant or infants or infant’s or “infant s” or infantile or infancy or newborn* or "new born" or "new borns" or "newly born" or neonat*
or baby* or babies or premature or prematures or prematurity or preterm or preterms or "pre term" or premies or "low birth weight" or
"low birthweight" or VLBW or LBW or ELBW or NICU AND CENTRAL:TARGET
3. #2 OR #1
MEDLINE via Ovid - Ovid MEDLINE(R) and Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Daily and Versions(R):
1. exp infant, newborn/
2. (newborn* or new born or new borns or newly born or baby* or babies or premature or prematurity or preterm or pre term or low birth
weight or low birthweight or VLBW or LBW or infant or infants or 'infant s' or infant's or infantile or infancy or neonat*).ti,ab.
3. 1 or 2
4. randomized controlled trial.pt.








13. exp animals/ not humans.sh.
14. 12 not 13
Musical and vocal interventions to improve neurodevelopmental outcomes for preterm infants (Protocol)









Cochrane Database of Systematic Reviews





20. ((single or doubl* or tripl* or treb*) and (blind* or mask*)).ti,ab.
21. placebo*.ti,ab.
22. 16 or 17 or 18 or 19 or 20 or 21
23. 2 and 22
24. limit 23 to yr="2018 -Current"
25. 15 or 24
CINAHL via EBSCOhost:
(infant or infants or infant’s or infantile or infancy or newborn* or "new born" or "new borns" or "newly born" or neonat* or baby* or babies
or premature or prematures or prematurity or preterm or preterms or "pre term" or premies or "low birth weight" or "low birthweight" or
VLBW or LBW) AND (randomized controlled trial OR controlled clinical trial OR randomized OR randomised OR placebo OR clinical trials
as topic OR randomly OR trial OR PT clinical trial)
Appendix 2. Risk of bias tool
We will use the standard methods of Cochrane and Cochrane Neonatal to assess the methodological quality of the trials. For each trial, we
will seek information regarding the method of randomisation, blinding and reporting of all outcomes of all the infants enrolled in the trial.
We will assess each criterion as being at a low, high, or unclear risk of bias. Two review authors will separately assess each study. We will
resolve any disagreement by discussion. We will add this information to the 'Characteristics of included studies' table. We will evaluate
the following issues and enter the findings into the 'Risk of bias' table..
1. Sequence generation (checking for possible selection bias). Was the allocation sequence adequately generated?
For each included study, we will categorize the method used to generate the allocation sequence as:
• low risk (any truly random process e.g. random number table; computer random number generator);
• high risk (any non-random process e.g. odd or even date of birth; hospital or clinic record number); or
• unclear risk.
2. Allocation concealment (checking for possible selection bias). Was allocation adequately concealed?
For each included study, we will categorize the method used to conceal the allocation sequence as:
• low risk (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);
• high risk (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth); or
• unclear risk
3. Blinding of participants and personnel (checking for possible performance bias). Was knowledge of the allocated intervention ade-
quately prevented during the study?
For each included study, we will categorize the methods used to blind study participants and personnel from knowledge of which inter-
vention a participant received. Blinding will be assessed separately for different outcomes or class of outcomes. We will categorize the
methods as:
• low risk, high risk or unclear risk for participants; and
• low risk, high risk or unclear risk for personnel.
4. Blinding of outcome assessment (checking for possible detection bias). Was knowledge of the allocated intervention adequately
prevented at the time of outcome assessment?
For each included study, we will categorize the methods used to blind outcome assessment. Blinding will be assessed separately for dif-
ferent outcomes or class of outcomes. We will categorize the methods as:
• low risk for outcome assessors;
• high risk for outcome assessors; or
• unclear risk for outcome assessors.
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5. Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations). Were incom-
plete outcome data adequately addressed?
For each included study and for each outcome, we will describe the completeness of data including attrition and exclusions from the
analysis. We will note whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with
the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across
groups or were related to outcomes. Where sufficient information is reported or supplied by the trial authors, we will re-include missing
data in the analyses. We will categorize the methods as:
• low risk (< 20% missing data);
• high risk (≥ 20% missing data); or
• unclear risk.
6. Selective reporting bias. Are reports of the study free of suggestion of selective outcome reporting?
For each included study, we will describe how we investigated the possibility of selective outcome reporting bias and what we found. For
studies in which study protocols were published in advance, we will compare prespecified outcomes versus outcomes eventually reported
in the published results. If the study protocol was not published in advance, we will contact study authors to gain access to the study
protocol. We will assess the methods as:
• low risk (where it is clear that all of the study's prespecified outcomes and all expected outcomes of interest to the review have been
reported);
• high risk (where not all of the study's prespecified outcomes have been reported; one or more reported primary outcomes were not
prespecified outcomes of interest and are reported incompletely and so cannot be used; study fails to include results of a key outcome
that would have been expected to have been reported); or
• unclear risk.
7. Other sources of bias. Was the study apparently free of other problems that could put it at a high risk of bias?
For each included study, we will describe any important concerns we had about other possible sources of bias (for example, whether there
was a potential source of bias related to the specific study design or whether the trial was stopped early due to some data-dependent
process). We will assess whether each study was free of other problems that could put it at risk of bias as:
• low risk;
• high risk; or
• unclear risk.
If needed, we plan to explore the impact of the level of bias through undertaking sensitivity analyses.
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